BiotechTube
Regis Technologies

Regis Technologies

Morton Grove, United States· Est.
registech.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Founded in 1956 and headquartered in Morton Grove, Illinois, Regis Technologies is a private, revenue-generating services company operating as a specialized CDMO and chromatography products manufacturer. Its core business model combines custom API development and manufacturing services with the sale of chromatography columns and media, creating a unique dual revenue stream. The company was recently acquired by ESTEVE Química, integrating it into a larger global CDMO platform while maintaining its operational brand and focus on complex small molecule projects.

Small MoleculesDrug DeliveryDiagnostics

Technology Platform

Integrated expertise in advanced organic synthesis (process chemistry, HPAPI handling) and chromatography science for the development and purification of complex small molecule APIs.

Opportunities

Leveraging the global platform and resources of parent company ESTEVE to access a wider client base and offer integrated services.
Growing demand for specialized CDMO services in complex small molecules, chiral chemistry, and HPAPI manufacturing.
The dual revenue stream from both CDMO services and proprietary chromatography products provides business model resilience.

Risk Factors

Client concentration and dependency on the success of clients' drug programs, which can be terminated at any phase.
High competition in the CDMO sector from larger, global players and other niche specialists.
Integration risks associated with the recent acquisition, potentially affecting culture and operations.

Competitive Landscape

Operates in the highly competitive small molecule API CDMO market, competing against large global players (e.g., Lonza, Catalent, Thermo Fisher) and numerous specialized chemistry-focused CDMOs. Its key differentiator is the combined expertise in synthesis and in-house chromatography product manufacturing, which is less common. As part of ESTEVE, it now competes as part of a larger, integrated global CDMO platform.

More companies in Small Molecule Drugs →More companies in United States →